HOUSTON--(BUSINESS WIRE)--IDEV Technologies, Inc.(”IDEV”), an emerging leader in the development and marketing of minimally invasive stent technologies, today announces receipt of 510(k) clearance for a new SUPERA™ Biliary Stent Delivery Catheter. The improved SUPERA™ Transhepatic Biliary System is indicated for the palliative treatment of biliary strictures produced by malignant neoplasms. The new SUPERA™ Biliary Stent Delivery Catheter is the first to offer a retrieval capability of up to 95% for a partially deployed SUPERA Biliary Stent. The SUPERA™ Biliary Stent Delivery Catheter also provides the operator with enhanced control during a procedure. A unique reciprocating ratchet mechanism allows the operator to precisely place the stent in the biliary tract.
